ImpediMed
Presence
ImpediMed is a company listed under the stock ticker IPD (AU).
Executives
View the org chart displaying its 15 main executives
Most searched biographies at ImpediMed
- Parmjot Bains, Managing Director and Interim Chief Executive Offic...
- Amit Patel, Non-Executive Director
- Jan West, Non-Executive Director
Popular executive movements at ImpediMed
- Rick Valencia, Chief Executive Officer and Managing Director, has left the company (posted on November 20 2023).
- Parmjot Bains has joined the company as Managing Director and Interim Chief Executive Officer (posted on November 20 2023).
- Don Williams, Non-Executive Chairman, has left the company (posted on October 3 2023).
Click here to view some more movements at ImpediMed
Create your alert
to follow the executive moves at ImpediMed.
Medical Equipment
ImpediMed has 977 competitors including Philips (Netherlands), Medtronic (Ireland) and Thermo Fisher Scientific (United States (USA)).
Popular M&A news in Medical Equipment
- Medigus will change its company name to Xylo Technologies on Apr 12, 2024. (posted on April 12 2024).
- Johnson & Johnson has announced the acquisition of Shockwave Medical (posted on April 6 2024).
- Carlsmed has just announced a $52 Million fundraising (posted on March 22 2024).
Popular contacts in Medical Equipment
News
Press releases by ImpediMed
- Early Detection of Lymphedema and Value of Compression Garments After Breast Cancer Treatments with Dr. Steven Chen | ImpediMed
- New Data Presented at the 2022 San Antonio Breast Cancer Symposium Shows Early Detection using L-Dex and Intervention Improves Lymphedema Progression-Free Survival
- ImpediMed Reaches Milestone of 500,000 Patient Tests Performed with the SOZO Digital Health Platform
- New Data Confirms Early Detection and Intervention of Lymphedema Improves Quality of Life for Breast Cancer Patients Who Avoid Chronic Lymphedema
- Current Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer-Related Lymphedema
- ImpediMed Expands Use of SOZO in Leading Cancer Centers Focused on Reducing the Impact of Lymphedema after Breast Cancer
- ImpediMed Announces U.S. Launch of Lymphedema Prevention Program with GenesisCare a Global Organization Dedicated to Care of Cancer Patients
- ImpediMed Announces Two Posters at Heart Failure Society of America Annual Scientific Meeting That Demonstrate Utility of SOZO® Digital Health Platform for Heart Failure Patients
- New Data Evaluating ImpediMed's SOZO® in Heart Failure Patients to be Presented at Heart Failure Society of America Annual Scientific Meeting 2022
- New Bone Data Showing Strong Correlation between ImpediMed's SOZO and DXA in Cancer Patients Presented at 39th Annual Miami Breast Cancer Conference
- View more press releases Close
Social media about ImpediMed
- ImpediMed on Wikipedia, Google News & Yahoo Finance
- ImpediMed on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Parmjot Bains 
